Liquid Labs USA, LLC d/b/a Likido Labs USA

Warning LetterOpen

Justin A. Jason Managing Member Liquid Labs USA, LLC d/b/a Likido Labs USA 2663 Saturn Street Brea , CA 92821-6785 United States justin@likidolabs.comFEI 3013901018Issued Feb 10, 2021Center for Tobacco Products

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3013901018.

Violations3

Issue DateFeb 10, 2021

Product TypeTobacco

StatusOpen

Letter Details

Firm: Liquid Labs USA, LLC d/b/a Likido Labs USA
Location: Justin A. Jason Managing Member Liquid Labs USA, LLC d/b/a Likido Labs USA 2663 Saturn Street Brea , CA 92821-6785 United States justin@likidolabs.com
FEI Number: 3013901018
Country: United States
Issue Date: February 10, 2021
Issuing Office: Center for Tobacco Products
Product Type: Tobacco
Status: Open

Summary

Liquid Labs USA, LLC was warned for manufacturing and distributing e-liquid tobacco products (Vape SZNS Salty SZN products in three flavors) without required FDA marketing authorization orders, rendering them adulterated under the Family Smoking Prevention and Tobacco Control Act. The company failed to obtain premarket review approval for these "new tobacco products" and did not provide required notices or information for the products, causing them to also be misbranded under FDA regulations.

Liquid Labs USA, LLC d/b/a Likido Labs USA FDA Warning Letter, February 10, 2021